Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: A randomized, double-blind, placebo-controlled study

Clinical Therapeutics

Volumn 29, Issue 1, 2007, Pages 99-109

  Ishkanian, Gary ^a   Blumenthal, Harvey ^b   Webster, Christopher J ^c   Richardson, Mary S ^c   Ames, Michael ^c  

^a Elkind Headache Center   (United States)

^b Neurological Associates of Tulsa   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; IBUPROFEN; MULTIVITAMIN; NAPROXEN; PARACETAMOL; PLACEBO; PSEUDOEPHEDRINE; SUMATRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEAD AND NECK DISEASE; HOT FLUSH; HUMAN; JAW DISEASE; JAW TENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; NECK TENSION; PHONOPHOBIA; PHOTOPHOBIA; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SINUS HEADACHE; SYMPTOMATOLOGY; TABLET; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; DIZZINESS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; PARANASAL SINUSES; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 33947182077     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.01.012     Document Type: Article

References (30)

1. Lipton R.B., Stewart W.F., Diamond S., et al. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 41 (2001) 646-657
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 Suppl 7 (1988) 1-96
3. Lipton R.B., Stewart W.F., Celentano D.D., and Reed M.L. Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med 152 (1992) 1273-1278
4. Lipton R.B., Diamond S., Reed M., et al. Migraine diagnosis and treatment: Results from the American Migraine Study II. Headache 41 (2001) 638-645
5. Osterhaus J.T., Gutterman D.L., and Plachetka J.R. Healthcare resource and lost labour costs of migraine headache in the US. PharmacoEconomics 2 (1992) 67-76
6. Lipton R.B., Stewart W.F., and Liberman J.N. Self-awareness of migraine: Interpreting the labels that headache sufferers apply to their headaches. Neurology 58 Suppl 6 (2002) S21-S26
7. Diamond M.L. The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine. Neurology 58 Suppl 6 (2002) S3-S9
8. Abstract. Cady R.K., Schreiber C.P., Cova R., et al. Self-described "sinus headache" in patients with clinician-diagnosed migraine headaches: Sinus or migraine?. Neurology 58 Suppl 3 (2002) A496
9. Schreiber C.P., Hutchinson S., Webster C.J., et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med 164 (2004) 1769-1772
10. Abstract. Schreiber C.P., Cady R.K., and Billings C. Oral sumatriptan for self-described "sinus" headache. Cephalalgia 21 (2001) 298
11. Abstract. Schreiber C.P., Cady R.K., Szeto S., et al. Treatment of selfdescribed "sinus headache" with oral sumatriptan in patients with self-described "sinus headache" in addition to clinician-diagnosed migraine headache. Neurology 58 Suppl 3 (2002) A128-A129
12. Available at:. European Agency for the Evaluation of Medicinal Products. Accessed January 8, 2007. International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6 (2002), WH, Geneva, Switzerland. http://www.emea.eu.int
13. Available at:. World Medical Association Declaration of Helsinki. Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects [WMA Web site]. Accessed (1996-January 8, 2007), WMA, Fern ey-Voltaire, France. http://www.wma.net
14. Evidence Report/Technology Assessment No. 9 (Contract 290-970019 to the New England Medical Center). Lau J., Zucker D., Engels E.A., et al. Diagnosis and treatment of acute bacterial rhinosinusitis (March 1999), Agency for Health Care Policy and Research, Rockville, Md
15. Lanza D.C., and Kennedy D.W. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117 (1997) S1-S7
16. Blumenthal H.J. Headaches and sinus disease. Headache 41 (2001) 883-888
17. Williams Jr. J.W., Simel D.L., Roberts L., and Samsa G.P. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med 117 (1992) 705-710
18. Abstract. Ware J., Kosinski M., Dahlof C., et al. Validity of HIT-6, a paper-based short form for measuring headache impact. Cephalalgia 21 (2001) 333
19. Ware Jr. J.E., Bjorner J.B., and Kosinski M. Practical implications of item response theory and computerized adaptive testing: A brief summary of ongoing studies of widely used headache impact scales. Med Care 38 (2000) 1173-1182
20. Abstract. Garber W.H., Kosinski M., Dahlof C., et al. HIT-6 reliably measures the impact of headache. Cephalalgia 21 (2001) 333
21. Abstract. Dowson A., Dahlof C., Malik F., and Pham B. A multicentre study investigating the association between disability (using Headache Impact Test HIT-6) and IHS classifica tion (as determined by an expert panel diary review). Cephalalgia 22 Suppl 1 (2002) 28
22. Pfaffenrath V., Cunin G., Sjonell G., and Prendergast S. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 1 00 mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan. Headache 38 (1998) 184-190
23. [published correction appears in Cephalalgia. 2003;23:71]. Ferrari M.D., Goadsby P.J., Roon K.I., and Lipton R.B. Triptans (serotonin, 5-HT1 B/1 D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22 (2002) 633-658
24. Rosbe K.W., and Jones K.R. Usefulness of patient symptoms and nasal endoscopy in the diagnosis of chronic sinusitis. Am J Rhinol 12 (1998) 167-171
25. Tarabichi M. Characteristics of sinus-related pain. Otolaryngol Head Neck Surg 122 (2000) 842-847
26. Barbanti P., Fabbrini G., Pesare M., et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia 22 (2002) 256-259
27. Edvinsson L. Sensory nerves in man and their role in primary headaches. Cephalalgia 21 (2001) 761-764
28. Uddman R., Longmore J., Cardell L.O., and Edvinsson L. Expression of 5-HT1 B receptors in human nasal mucosa. Acta Otolaryngol 121 (2001) 403-406
29. Hardebo J.E. Subcutaneous sumatriptan in cluster headache: A time study of the effect of pain and autonomic symptoms. Headache 33 (1993) 18-21
30. Barbanti P., Fabbrini G., Vanacore N., et al. Sumatriptan in migraine with unilateral cranial autonomic symptoms: An open study. Headache 43 (2003) 400-403